Fundz

Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.

PRIVATEJun 03, 2025

Amount Raised

$10 Million

Round Type

Series A

New YorkInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMedical

Investors

Brooklyn Bridge VenturesFJ LabsTelescope Partners

Description

Canid has successfully raised $10 million in a Series A funding to enhance its AI-driven vaccine management platform. This funding aims to streamline processes for pediatricians, reducing their administrative workload significantly. The investment will also help in further developing and deploying the technology. Canid’s innovative approach is set to revolutionize vaccine management.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Canid that raised within 45 days of this round, from Fundz verified event records.

  • Lucem Health raised $2.3M on July 8, 2025.
  • Shuttle Pharmaceutical Holdings raised $4.3M (Seed) on June 20, 2025.
  • Nabla raised $70M (Series C) on June 17, 2025.
  • Hoppr raised $32M (Series A) on June 17, 2025.
  • Positron raised $75M on June 16, 2025.
  • Cosm Medical raised an undisclosed amount (Seed) on June 5, 2025.

Who to call at Canid, and when

A new round usually means Canid is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Canid raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Canid, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Canid. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Canid

Location

New York, New York, United States

About

Canid is revolutionizing pediatric vaccine management by turning the complex and expensive process of giving a vaccine into a simple scan-and-go workflow. Canid’s platform integrates directly with electronic health record systems and uses AI, software and economies of scale to drastically reduce the time and money pediatricians must spend on this crucial but burdensome process.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Canid raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Canid's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Canid raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.